Type 2 Diabetes Clinical Trial
Official title:
Development and Evaluation of A Peer Support Program for Type 2 Diabetes Patients in Hong Kong as Quality Improvement in Diabetes Care Service
This is a pre-and-post study with a study duration of one year involving 7 diabetes centres in Hong Kong. A group of motivated patients with type 2 diabetes will be trained as peer supporters in two training workshops. Patients who may benefit from peer support program will be recruited as peers. In the one year study period, peer supporters are required to have 2 face-to-face interviews and 12 phone calls. Clinical parameters and psycho-behavioral parameters of both peer supporters and peers will be evaluated at the baseline and at the end of the study.
Aim of the Study:
1. To evaluate the impact of peer support program on various clinical, psycho-behavioral
outcomes and health utilization outcomes in Hong Kong Chinese with type 2 diabetes
2. To evaluate the feasibility of a peer support program in Hong Kong
3. To evaluate the sustainability of a peer support program in Hong Kong
Duration of the program = 12 months
Indicators and targets:
- Number of peer supporters recruited: 12
- Number of peers recruited = 50
- Number of peer supporter training sessions = 2
- Number of reunion sessions for peer supporters with the investigators = 4
- Minimum number of telephone calls made by peer supporter = 12 for each peer
Method:
1. The diabetes nurses from 7 diabetes centres of public hospitals in Hong Kong will
recruit peer supporters and peers in the first 3 months of the project.
2. Nurses will compile list of potential patients to invite to become peer supporters.
3. Selected potential peer supporters will attend 2 half-day training sessions by the
diabetes nurses and social workers from the Community Rehabilitation Network according
to specially-designed curriculum. In sum, it includes revision of diabetes knowledge,
self-management, lifestyle modification, debriefing and rapport building skills.
Patients will be evaluated at the end of the training course by social workers and
nurses to ensure they are ready to be peer supporters.
4. Diabetes nurses will recruit patients as peers when they attend to the diabetes centre
for routine diabetes care services such as complication screening, diabetes group
education and nurse-led clinics.
5. Each peer supporter will be matched to 5 peers in the beginning. In case when the peer
supporter quitted before the study ends, his/her peers will be directed to another peer
support group. The maximum number of peers in each support group is 6.
6. A 2-hour face-to-face introduction of the peer supporters and peers will be held at the
diabetes centre when the study begins.
7. Peer supporters will be expected to carry out a minimum of12 phone calls over the next
12 months (one call every 2 weeks for 3 months; one call every month for the second 3
months, one call every 2 months for the last 6 months). Calls will be guided by a call
checklist. Both peer supporters and peers will be encouraged to call one another ad
lib. Peer supporters will return checklists to the program coordinator, recording the
frequency, length, and nature of their interactions with peers
In the first month of the peer support group, social workers from the Community
Rehabilitation Network will contact peer leaders by phone to further foster the peer
leader to be committed to the program and to increase their confidence in supporting
their peers.
Two large gatherings for all participants will be organized by the investigators at
around 4-8 months after the study and near to the study completion.
8. All peer supporters and peers will receive usual medical follow-up at their original
clinics.
9. Peer supporters will have reunion workshop at the diabetes centre with the nursing team
and social worker every 2 months throughout the intervention. The workshop will last
around 1 hour and it will address any issues the peer supporters encounter, provide
some educational by a medical professional, and will facilitate sharing amongst peer
supporters to develop a peer supporter network.
10. Surveys for peer supporters and involved staff will also be collected during the
debriefing sessions to identify difficulties peer supporters are facing and to better
inform ongoing training and education. Surveys will also be administered to peers at
the end of the study to obtain opinions and suggestions about their peer support
experience.
11. The intervention duration will be 12 months. However peers are encouraged to keep
regular contact with peer leaders even after the intervention period ends.
12. A focus-group interview will be conducted by a trained psychologist to two of the peer
groups to evaluate participants' satisfaction
Progress tracking:
Clinical, behavioral, and psychological data will be collected at baseline and at the end of
the study (12 months):
1. Clinical measures to be done in introduction session and in the second large group
gathering: Blood pressure Adiposity (body weight, waist circumference and body mass
index)
2. Biochemical measures (HbA1c and lipid profile) were retrieved via the hospital Central
Computer System within 2 months of the study starting date and the end date
3. Psychological measures, using validated self-administered questionnaires, to be
completed in introduction session and in the second large group gathering:
World Health Organization quality of life questionnaire (WHO-QoL-26) for quality of life
15-item Chinese Diabetes Distress Scale (CDDS-15) for diabetes distress 8-item Patient
Health Questionnaire for depressive symptoms EQ5D for quality of life Summary of Diabetes
Self Care Activities (SDSCA) for adherence to diabetes self-care
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |